Quick Answer
MACROGENICS INC reported Research And Development Expense of $147.17 million for the year ending 2025.
- MACROGENICS INC showed a decrease of -16.9% in Research And Development Expense from 2024 to 2025.
- This data is from MACROGENICS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), MACROGENICS INC's Research And Development Expense has grown by 258.2%.
- Historical annual values: Fiscal year 2025: $147.17 million | Fiscal year 2024: $177.19 million | Fiscal year 2023: $166.58 million | Fiscal year 2022: $207.03 million | Fiscal year 2021: $214.58 million | Fiscal year 2020: $193.20 million | Fiscal year 2019: $195.31 million | Fiscal year 2018: $190.83 million | Fiscal year 2017: $147.23 million | Fiscal year 2016: $122.09 million | Fiscal year 2015: $98.27 million | Fiscal year 2014: $70.19 million | Fiscal year 2013: $46.58 million | Fiscal year 2012: $45.43 million | Fiscal year 2011: $41.09 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: